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Abstract 
Purpose: This multidisciplinary industrial research project sets out to develop a hybrid 
clinical decision support mechanism (inspired by ontology and machine learning 
driven techniques) by combining evidence, extrapolated through legacy patient data 
to facilitate cardiovascular preventative care.
Methods: The proposed cardiovascular clinical decision support framework comprises 
of two novel key components:(1) Ontology driven clinical risk assessment and recom-
mendation system (ODCRARS) (2) Machine learning driven prognostic system (MLDPS). 
State of the art machine learning and feature selection methods are utilised for the 
prognostic modelling purposes. The ODCRARS is a knowledge-based system which is 
based on clinical expert’s knowledge, encoded in the form of clinical rules engine to 
carry out cardiac risk assessment for various cardiovascular diseases. The MLDPS is a 
non knowledge-based/data driven system which is developed using state of the art 
machine learning and feature selection techniques applied on real patient datasets. 
Clinical case studies in the RACPC, heart disease and breast cancer domains are con-
sidered for the development and clinical validation purposes. For the purpose of this 
paper, clinical case study in the RACPC/chest pain domain will be discussed in detail 
from the development and validation perspective.
Results: The proposed clinical decision support framework is validated through clini-
cal case studies in the cardiovascular domain. This paper demonstrates an effective 
cardiovascular decision support mechanism for handling inaccuracies in the clinical 
risk assessment of chest pain patients and help clinicians effectively distinguish acute 
angina/cardiac chest pain patients from those with other causes of chest pain.
Conclusion: The new clinical models, having been evaluated in clinical practice, 
resulted in very good predictive power, demonstrating general performance improve-
ment over benchmark multivariate statistical classifiers. Various chest pain risk assess-
ment prototypes have been developed and deployed online for further clinical trials.
Keywords: Clinical decision support framework, Cardiovascular decision support 
framework, Hybrid clinical decision support framework
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Introduction
The adoption of clinical decision support systems (CDSSs) in the diagnosis and admin-
istration of major chronic diseases e.g. (Dementia Lindgren 2011), cancer, diabetes 
(OConnor et al. 2011), hypertension (Luitjes et al. 2010) and heart disease (DeBusk et al. 
2010) have made significant contributions in improving the clinical outcomes at primary 
and secondary care healthcare organisations all over the world. CDSS have also made it 
possible for system developers and knowledge engineers to collate and construct domain 
expert knowledge for the purpose of clinical risk assessment and screening by clinicians 
(Khong and Ren 2011).
Clinical decision support systems are being extensively deployed in healthcare settings 
all over the world. Modern clinical decision support systems are increasingly dissimilar 
to each other, despite following the same generic architecture which defines a typical 
CDSS (Burstein et al. 2011). These clinical decision support systems incorporate a vari-
ety of innovative techniques to perform various key operations which include clinical 
knowledge dissemination and collecting patient’s medical history for effective clinical 
decision making. These systems aim to provide clinical decision support and automatic 
personalised clinical advice through inference capabilities (Mohiuddin 2011). They also 
help to streamline clinical workflows through integration with electronic healthcare 
records for patient clinical history collection, diagnosis, inference and training.
Clinical decision support operations are an integral part of modern healthcare man-
agement systems. They assist clinicians, patients and healthcare stakeholders by pro-
viding expert clinical knowledge and patient-centric information (Classen et al. 2011). 
The information provided by these intelligent clinical systems is used for clinical deci-
sion making in order to improve the effectiveness and quality of healthcare. Automated 
cardiovascular decision support systems are now being deployed in hospitals and pri-
mary care organizations in order to meet the ever growing clinical needs of prognosis 
in the areas of cardiovascular disease and coronary heart disease. Computerized deci-
sion support strategies have already been implemented successfully in several areas of 
cardiovascular care (Kuperman et  al. 2007). These applications are being used as part 
of the extension of clinical informatics infrastructure in the UK and US. These systems 
are also being used in both primary and secondary care settings for providing efficient 
healthcare delivery to its patients. In order to capitalise on the benefits provided by car-
diovascular decision support systems, a strong foundation in evidence-based medicine 
and well-established clinical practice guidelines (CPGs) have to be considered to ensure 
clinical governance in the next generation clinical systems.
Background
Ontology driven clinical decision support frameworks
An ontology is an explicit specification of a conceptualization. The term is borrowed 
from philosophy, where an ontology is a systematic account of existence. For AI systems, 
what “exists” is that which can be represented. When the knowledge of a domain is rep-
resented in a declarative formalism, the set of objects that can be represented is called 
the universe of discourse. This set of objects, and the describable relationships among 
them, are reflected in the representational vocabulary with which a knowledge-based 
program represents knowledge. Thus, in the context of AI, we can describe the ontology 
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of a program by defining a set of representational terms. In such an ontology, defini-
tions associate the names of entities in the universe of discourse (e.g., classes, relations, 
functions, or other objects) with human-readable text describing what the names mean, 
and formal axioms that constrain the interpretation and well-formed use of these terms. 
Formally, an ontology is the statement of a logical theory (Gruber 1993). Ontologies are 
often equated with taxonomic hierarchies of classes, but class definitions, and the sub-
sumption relation, but ontologies need not be limited to these forms. Ontologies are also 
not limited to conservative definitions, that is, definitions in the traditional logic sense 
that only introduce terminology and do not add any knowledge about the world (Her-
bert and Enderton 1972).
The Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) is an 
onto-logical resource specifically developed some thirty years ago with a view to stand-
ardize healthcare systems. SNOMED CT and with UMLS are clinical thesauruses, aim-
ing to resolve documentation standardization issues in clinical systems. These are large 
scale medical taxonomies which have been exploited in modern clinical systems show-
ing significant good results in the targeted clinical systems. In Mortensen et al. (2014) 
it shows that the clinicians using healthcare systems equipped with SNOMED outper-
formed clinicians using conventional systems without SNOMED CT capabilities.
Machine learning driven cardiovascular decision support systems
Machine learning refers to a type of artificial intelligence algorithm designed to identify 
patterns in input data, such as patient characteristics, in order to perform complex clas-
sification tasks. Machine learning based clinical decision support systems can avoid the 
bottleneck of knowledge acquisition because knowledge is directly learned through the 
clinical data. In addition, ML-based clinical decision support systems are able to give 
recommendations that are generated by non-linear forms of knowledge, and are easily 
maintainable by simply adding new cases (Chi 2009).
In Nahar et  al. (2013), a number of computational intelligence techniques were uti-
lised in the detection of heart disease as a preventative measure. A comparative analy-
sis of six well-known machine learning classifiers was carried out using the Cleveland 
heart disease dataset. Authors introduced medical knowledge driven feature selection 
(MFS) and it was compared against the state of the art feature selection algorithms. 
Their experimental results showed that machine learning classification combined with 
MFS significantly improved the performance of binary classification. MFS feature selec-
tion technique was combined with computerised feature selection process to further 
refine classification accuracies obtained in previous iterations. MFS combined with 
Naive Bayes and Sequential minimal optimisation (SMO for training of support vector 
machine) provided the best classification accuracies and TP (true positive) and F-meas-
ure resulted in a higher performance as compare to experimental setups based on state 
of the art feature selection techniques combined with machine learning classifiers.
We proposed an ontology and machine learning driven hybrid clinical decision sup-
port framework for cardiovascular preventative care as shown in Fig.  1. The develop-
ment of the machine learning driven prognostic system (MLDPS) was carried out in 
close collaboration with clinical experts. The rapid access chest pain clinic’s case study 
was identified by the consultant cardiologist from Raigmore Hospital in Inverness, UK. 
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The key objective of the RACPC clinical case study was to help improve the diagnos-
tic and performance capabilities of the RACPC. The heart disease clinical case study 
was carried out in collaboration with general medical practitioners from UK in order to 
develop a preventative care mechanism for patients who are at risk of developing heart 
disease.
The ODCRARS is a knowledge-based system which is based on clinical expert’s 
knowledge, encoded in the form of clinical rules (utilised by the clinical rules engine) 
to carry out cardiac risk assessment for various cardiovascular diseases. The MLDPS 
is a non knowledge-based/data driven prognostic system which is developed by apply-
ing machine learning and feature selection techniques on legacy patient datasets. This 
approach eliminates the need for writing clinical rules thereby reducing dependency on 
clinical experts to encode their advice in the clinical decision making. Non-knowledge 
based clinical decision support systems are utilised in providing point-of-care clinical 
decision making and implementation of such solutions facilitate development of cost 
effective solutions with improvement in the quality of care provided.
Fig. 1 A novel ontology and machine learning-driven hybrid clinical decision support framework for cardio-
vascular preventative care
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The rest of this paper will be in sections: In “Background” section, we provide a 
detailed description of the novel machine learning driven prognostic system based on 
the chest pain clinical case study and the complete development life cycle followed by 
validation results. At the end we conclude our findings and provide future directions of 
our research.
Methods
MLDPS development based on rapid access chest pain clinic’s clinical case study
An iterative development process, based on machine learning and feature selection has 
been utilised in the development of machine learning driven prognostic models. The 
MLDPS’s development process is general enough to handle a variety of healthcare data-
sets which will enable researchers to develop cost effective and evidence based clinical 
decision support systems. For the purpose of this paper, development and validation of 
the MLDPS based on the chest pain clinical case study will be discussed in detail. The 
key stages of the prognostic model development process are shown in Fig. 2. The general 
description of each stage is as follows:
Results and discussion
The consultant cardiologist from Raigmore Hospital specified a revised clinical require-
ment to break original patient dataset down into clinical risk factors and lab test results 
and create two new study groups. The key clinical objective of introducing this demarca-
tion amongst clinical risk factors and lab results was to evaluate the impact of classifica-
tion results using these two new datasets. So two new study cohorts were created for 
this purpose as shown in Table 1, so that a comparison could be drawn among two study 
groups. Another clinical requirement was to compare the clinical effectiveness of two 
models separately and to classify chest pain patients (predicting risk of cardiac or non 
Fig. 2 Schematic view of the prognostic model development process. 1 data acquisition, 2 data pre-process-
ing, 3 feature selection, 4 prognostic model development, 5 prognostic model validation and evaluation, 6 
online clinical prognostic model
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cardiac chest pain) purely on the basis of the risk factors and test results information 
independently.
For the comparative analysis, the original patient dataset was distributed into two 
study sets as follows:
A detailed comparative analysis of some of the most sophisticated machine learning 
classifiers combined with state of the art feature selection techniques were utilised for 
data classification purposes. Experimental setups comprises of the logistic regression 
(LR), decision tree (DT) and support vector machine (SVM) classifiers combined with 
forward selection (FS), backward selection (BS), sequential forward floating selection 
(SFFS), P value feature selection, minimum redundancy and maximum relevance feature 
selection (mRMR) techniques were utilised. The expert driven (ED) feature selection i.e. 
pre-selected clinical variables by the clinical domain expert is compared with the state of 
the art feature selection techniques.
Study group 1: clinical risk factors
In the study group 1, patient demographics including clinical risk factors are included 
for the comparative analysis purpose. In the first stage, state of the art machine learn-
ing classifiers and feature selection techniques are utilised. The experimental setups 
used for this purpose are shown in the Table 2. Candidate clinical variables preselected 
by the clinical domain expert were classified using the LR, DT and SVM classifiers and 
results were compared with the state of the art feature selection methods as shown in 
our experimental setups. The purpose of expert-driven (ED) data classification was to 
develop a baseline model using the LR classifier.
As it can be seen in Table 2, the LR based classification setups combined with back-
ward feature selection method (smoker, number of years smoking, age, diabetes type and 
raised cholesterol) were able to classify the RACPC patient dataset with a classification 
accuracy of 68.99  %. Also, it is interesting to find out that the DT combined with BS 
feature selection method classified the patient dataset with a classification accuracy of 
65.05 % using just one feature, which is patient’s age. The SVM combined with FS, clas-
sified the patient dataset with a classification accuracy of 70.07 % using patient’s age, sex 
and hypertension. In the case of SVM (linear kernel function), similar clinical variables 
were picked up by the BS wrapping technique.
Table 1 Clinical risk factors and test results in two study groups
Study group 1 Study group 2
Risk factors Lab test results
1 Smoker Pathway
2 No of cigarettes Initial assessment
3 Number of years smoking ETT result
4 Age CT result
5 Sex MPS result
6 Diabetes type Angio result
7 Hypertension
8 Raised cholesterol
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SFFS, is classed as a refined forward selection method, is also utilised in all of our 
clinical case studies. Results of SFFS combined with LR, DT and SVM, were compared 
with the BS, FS, P value and mRMR methods to analyse its effectiveness. The results of 
SVM + SFFS with a more transparent logistic regression based model combined with 
BS, demonstrate that using three clinical variables, patient’s cardiac chest pain can be 
distinguished (whether it is cardiac or non-cardiac). So performance complexity trade-
offs can be considered if the clinical support decision function requires higher degree of 
accuracy by comprising on transparency of a clinical prognostic model.
Evaluation
After extracting features and identifying those with most discriminative power for each 
classifier, k-fold cross validation, leave-one-out validation (LOOCV) is performed in 
order to assess the performance of these classifiers. The experimental results reported 
in confusion matrices show that the LR + BS, DT + FS and SVM + SFFS are the best 
classification setups given the imbalanced nature of the patient dataset. Because our 
two classes (cardiac and non cardiac) are not equally distributed, different evaluation 
measurements are reported, namely weighted accuracy, unweighted accuracy, preci-
sion, recall,F-measure and Matthew’s correlation are reported in Table 4. The confusion 
matrices for LR, DT and SVM based classification setups and weighted classification 
accuracies are reported in Tables 3, 5 and 6. True positive (TP), false negative (FN), false 
positive (FP), true negative (TN) rates are provided for the actual and predicted outputs 
(classification outputs).
In order to quantify performances of the best classification setups, the Receiver Oper-
ating Characteristic (ROC) curves are used as shown in Fig. 3 (evaluating the underlying 
area), which compare the specificity and sensitivity of experimental setups. In clinical 
domain, ROC curve analysis is used to determine the cut off value for a clinical test. 
Table 2 Study group 1 (risk factors)- feature selection
Experimental setup Selected features Accuracy
1 LR + FS 4, 5, 6, 2, 1, 3 68.45
2 LR + BS 1, 3, 4, 5, 6, 8 68.99
3 LR + ED All 66.12
4 LR + SFFS 4, 5 ,6 67.92
5 LR + P-value 4, 5, 7, 8, 6, 3, 1, 2 66.12
6 LR + mRMR 4, 5, 7, 6, 8, 3, 1, 2 66.12
7 DT + FS 4, 7, 8, 6, 2 65.41
8 DT + BS 4 65.05
9 DT + ED All 62.36
10 DT + SFFS 4 65.05
11 DT + P value 4, 5, 7, 8, 6, 3, 1, 2 62.36
12 DT + mRMR 4, 5, 7, 6, 8, 3, 1, 2 62.36
14 SVM + FS 4, 5,1 70.07
15 SVM + BS 4, 5, 7 69.71
16 SVM + ED All 68.45
17 SVM + SFFS 4, 5, 1 70.07
18 SVM + P value 4, 5, 7, 8, 6, 3, 1, 2 68.45
19 SVM + mRMR 4, 5, 7, 6, 8, 3, 1, 2 68.45
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The ROC curve is a graph of sensitivity (y-axis) vs. 1- specificity (x-axis). Maximizing 
sensitivity corresponds to some large y value on the ROC curve. Maximizing specific-
ity corresponds to a small x value on the ROC curve. Thus a good first choice for a test 
cut-off value is that value which corresponds to a point on the ROC curve nearest to the 
Table 3 The confusion matrix of LR and feature selection based classification setups, study 
group 1
Predicted output
Actual LR+FS LR+BS LR+ED LR+SFFS LR+P LR+mRMR
 A 197 87 193 91 188 96 194 90 188 96 188 96
 B 89 185 82 192 93 181 89 185 93 181 93 181
 Accu-
racy
68.45 68.99 66.12 67.92 66.12 66.12
Table 4 Experiment results in terms of different evaluation measurements
LR + BS (%) DT + FS (%) SVM + SFFS (%)
Weighted accuracy 68.99 65.41 70.07
Unweighted accuracy 69.01 65.38 70.18
Precision 67.96 66.90 63.73
Recall 70.18 65.74 73.88
Fmeasure 69.05 66.32 68.43
Matthew’s correlation 38.03 30.78 40.67
Table 5 Confusion matrix of  DT and  feature selection based classification setups, study 
group 1
Predicted output
DT + FS DT + BS DT + ED DT + SFFS DT + P DT + mRMR
Actual
 A 190 94 170 114 169 115 170 114 169 115 169 115
 B 99 175 81 193 95 179 81 193 95 179 95 179
 Accuracy 65.41 65.14 62.3656 65.05 62.36 62.36
Table 6 Confusion matrix of SVM and feature selection based classification setups, study 
group 1
Predicted output
SVM + FS SVM + BS SVM + ED SVM + SFFS SVM + P SVM + mRMR
Actual
 A 181 103 183 101 179 105 181 103 179 105 179 105
 B 64 210 68 206 71 203 64 210 71 203 71 203
 Accuracy 70.07 69.71 68.45 70.07 68.45 64.45
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upper left corner of the ROC graph. This is not always true however. For example, in the 
cardiac risk assessment it is important not to miss detecting a patient with cardiac chest 
pain therefore it is more important to maximize sensitivity (minimize false negatives) 
than to maximize specificity. In this case the optimal cut-off point on the ROC curve will 
move from the vicinity of the upper left corner over toward the upper right corner.
Performance evaluation of experimental setups
In addition to the ROC curve analysis which is used to evaluate the performance of best 
classification setups. A one way ANOVA (analysis of variance) is also employed to com-
pare means of classification accuracies obtained in three experimental setups to establish 
whether the difference in classification accuracies within groups and among other clas-
sifiers is significant or they are statistically equal. Table 7 shows detailed analysis of the 
one-way ANOVA test which is performed using LR, DT and SVM experimental setups.
In the summary section, it shows the average classification accuracies of the LR,DT 
and SVM classification groups.
For the single factor Anova test, the null hypothesis is defined as follows:
H0 : µ1 = µ2 = µ3 (the means are all equal, hence the difference in means in all of 
three experimental setups are all the same)
H1 : At least two of the means are different
α = 0.05
In the ANOVA section in Table  7, sum of squares (SS), degree of freedom (df ) and 
mean square values are provided. As it can be seen that the F statistic value (28.34) is 



























Fig. 3 ROC curves of various experimental setups utilised in the study group 1 for comparison purpose
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greater than the critical value of F (8.02). Also the P value is <0.05, so on this basis the 
null hypothesis is rejected and it is now established that the difference in the classifica-
tion accuracies within groups and among other classifiers is statistically significant.
Study group 2: lab test results
In this study group, clinical variables representing various lab test results are included 
for the comparative analysis purpose. The statistical P values for the clinical variables 
involved in this study group are provided in Table 8. It shows that the “Pathway”, “Ini-
tial assessment”, “ETT” and “CT result” are the most significant clinical variables 
in the list. The state of the art feature selection and machine learning techniques are 
applied. Details of the LR, DT and SVM based machine learning setups are provided in 
the Table 9. As it can be seen, that 18 experimental setups are employed to classify the 
patient data in study group 2. An expert driven (pre-selection by clinical domain expert) 
feature selection and LR based baseline model was developed which was then compared 
with state of the art machine learning and feature selection techniques.
As it can be seen in the Table  9, “initial assessment” is a common clinical variable 
amongst the majority classification groups. It is interesting to notice that LR + FS and 
LR + SFFS based experimental setups attained the best classification accuracy using only 
one variable (initial assessment). The best classification setups are DT + FS, DT + BS, 
DT  +  SFFS. All of these setups handled the data sparsity issue with a classification 
accuracy of 82.97 %. “CT scan result” is also found to be common among the majority 




 Groups Count Sum Average Variance
 Logistic regression 6 403.72 67.28 1.7478
 Decision tree 6 382.59 63.765 2.38611
 Support vector machine 6 415.2 69.2 0.69228
ANOVA
 Source of variation SS df MS F P value F crit
 Between Groups 91.20 2 45.60 28.34 8.02793E-06 3.68
 Within Groups 24.13 15 1.6087
 Total 115.3354944 17
Table 8 P values of the clinical variables (study group 2)
Clinical variables P value
Lab test results
1 Pathway 1.93e−27 <0.00000
2 Initial assessment 1.48e−21 <0.00000
3 ETT result 0.04 <0.05
4 CT result 0.05 <0.1
5 MPS result 0.17
6 Angio result 0.9
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classification groups. These findings corroborate the high statistical P values of “Initial 
assessment and CT scan result” and re-iterate their significance in the clinical decision 
making. The performance complexity trade-offs in this case could be considered to limit 
the amount of tests (by focussing on the most significant tests picked up in the classifica-
tion setups), needed to diagnose a patient with cardiac chest pain.
Evaluation
After the feature extraction stage, a k-fold cross validation based leave-one-out valida-
tion (LOOCV) technique is used for performance evaluation of the classification meth-
ods. The confusion matrices of LR, DT and SVM combined with state of the art feature 
selection techniques are shown in Tables 5, 6 and 11.
The DT  +  FS, DT  +  SFFS, DT  +  BS and DT  +  mRMR classification groups are 
selected for analysis. In Table  10, different evaluation measurements are provided. 
As our two classes (cardiac and non cardiac) are not equally distributed which is why 
weighted accuracies and other measurements are reported. The confusion matrices of 
LR, DT and SVM based classification setups and weighted classification accuracies are 
Table 9 Feature selection results, study group 2 (test results)
Experimental setup Selected features Accuracy (%)
1 LR  + FS 2 69.89
2 LR + BS 1 ,4 ,5, 6 72.58
3 LR + ED All 67.92
4 LR + SFFS 2 69.89
5 LR + P value 6,2,5,1,4,3 67.92
6 LR + mRMR 2,6,1,5,4,3 67.92
7 DT + FS 2, 6, 4, 3 82.97
8 DT + BS 2, 3, 4, 6 82.97
9 DT + ED All 81.89
10 DT + SFFS 2, 6, 4, 3 82.97
11 DT + P value 6,2,5,1,4,3 81.89
12 DT + mRMR 2,6,1,5,4,3 81.89
14 SVM + FS 2,3 70.96
15 SVM + BS 2,4,5 70.96
16 SVM + ED All 68.63
17 SVM + SFFS 2,3 70.96
18 SVM + P value 6,2,5,1,4,3 68.63
19 SVM + mRMR 2,6,1,5,4,3 68.63
Table 10 Experiment results in terms of different evaluation measurements
DT + FS (%) DT + SFFS (%) DT + BS (%) DT + mRMR (%)
Weighted accuracy 82.97 81.89 82.97 82.97
Unweighted accuracy 83.09 81.98 83.09 83.09
Precision 76.41 77.46 76.41 76.41
Recall 88.57 85.60 88.57 88.57
Fmeasure 82.04 81.33 82.04 82.04
Matthew’s correlation 66.68 64.15 66.68 66.68
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provided in Tables 11, 12 and 13. True positive (TP), false negative (FN), false positive 
(FP), true negative (TN) rates are provided for the actual and predicted outputs.
The receiver operating characteristic (ROC) curves are used to quantify performances 
of the best classification groups. In Fig. 4, performances of DT and LR based setups are 
plotted which compare the specificity and sensitivity in our experimental setups.
Performance evaluation of experimental setups
In addition to the ROC curve analysis, a one way ANOVA test is also utilised for the 
performance evaluation of the best classification groups. The one-way ANOVA test is 
used to compare means of classification accuracies obtained in three experimental set-
ups. This test is used to ascertain whether the difference/improvement in classification 
accuracies within different classification groups and other classifiers (across different 
classification methods) is significant or they all are equal.
Table 14 provides detailed analysis of the one-way ANOVA. In the summary section, 
the average classification accuracies are calculated based on LR, DT and SVM classifica-
tion setups.
Table 11 Confusion matrix obtained using LR based classification setups
Predicted output
LR + FS LR + BS LR + ED LR + SFFS LR + P LR + mRMR
Actual
 A 142 142 248 36 206 78 142 142 206 78 208 78
 B 26 248 117 157 101 173 26 248 101 173 101 173
 Accuracy (%) 69.89 72.58 67.92 69.89 67.92 67.92
Table 12 Confusion matrix obtained using DT based classification setups
Predicted
DT + FS DT + BS DT + ED DT + SFFS DT + P DT + mRMR
Actual
 A 217 67 217 67 220 64 217 67 220 64 220 64
 B 28 246 28 246 37 237 28 246 37 237 37 237
 Accuracy (%) 82.97 82.97 81.89 82.97 81.89 81.89
Table 13 Confusion matrix obtained using SVM based classification setups
Predicted output
SVM + FS SVM + BS SVM + ED SVM + SFFS SVM + P value SVM + mRMR
Actual
 A 142 142 142 142 214 70 142 142 214 70 214 70




70.96 70.96 68.63 70.96 68.63 68.63
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For the single factor ANOVA test, the null hypothesis is declared as follows:
H0 : µ1 = µ2 = µ3 (the means are all equal, hence the difference in means in all of 
three experimental setups are all the same)
H1 : At least two of the means are different
α = 0.05
In the ANOVA section in Table 14, sum of squares (SS), degree of freedom (df ) and 
mean square values are provided. As it can be seen that the F statistic value (183.50) 
is greater than the critical value of F (3.682). Also the P value is <0.05, so on this basis 
the null hypothesis is rejected and it is now established that the difference in the 


























Fig. 4 ROCs for various experimental setups utilised in test results (study group 2) for comparison purpose
Table 14 One-way ANOVA Test for the performance evaluation of LR, DT and SVM based 
classification setups (study group 2- test results)
Anova: single factor
Summary
 Groups Count Sum Average Variance
 Logistic regression 6 416.12 69.35 3.4301
 Decision tree 6 494.58 82.43 0.34992
 Support vector machine 6 418.77 69.795 1.62867
ANOVA
 Source of variation SS df MS F P value F crit
 Between groups 661.6750111 2 330.83 183.50 2.8522E−11 3.682
 Within groups 27.04368333 15 1.802912222
 Total 688.7186944 17
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classification accuracies within groups and among other classifiers (across LR, DT and 
SVM classification groups) is statistically significant. 
Implementation of online clinical prognostic models
In the RACPC clinical case study, three datasets are utilised for the development of 
machine learning prognostic models for Raigmore Hospital’s RACPC clinicians. The 
results obtained through three patient datasets were analysed by the consultant cardiol-
ogist from Raigmore Hospital. It was decided to develop online cardiac chest pain prog-
nostic models based on LR based classification setups which are shown in Table 15. The 
cardiac chest pain prognostic model has been developed using the first patient dataset 
containing both patient demographics and lab test results information. This was selected 
by the clinical domain experts for further development. Two expert driven RACPC car-
diac chest pain prognostic models have also been developed and deployed online for 
clinical validation.
Logistic regression-based cardiac chest prognostic models have been developed and 
deployed online for the initial clinical validation by the consultant cardiologist from 
Raigmore hospital. Clinical questionnaires are encoded in HTML; logistic regression 
model is programmed in PHP, which generates an HTML page after data is collected 
from an HTML input form. The probability of cardiac chest pain risk score is calculated 
when user presses the “calculate score” button.
The machine learning cardiac chest pain prognostic model is intended to be used by 
RACPC clinicians. The user is asked to provide patient demographics information and 
details of CT, ETT and MPS lab test results. The cardiac chest pain risk score is calcu-
lated using the formula as shown below:
SCORE = 100.(1+ e−M)−1
where
M co-efficients of each clinical variable used in the model.
The logistic regression model calculates the probability of cardiac chest pain using 
series of inputs as shown in Fig. 6.
The initial cardiac chest pain prognostic model as in Fig. 5 was validated by clinical 
domain expert from Raigmore Hospital. In the developed cardiac chest pain prognostic 
Table 15 Classification setups considered for the development of machine learning driven 
cardiac chest pain prognostic model
Best classification setups
Risk factors and test results




LR + FS INA, AGE, ANG, SEX, MPS, YOS, NOC, HPT, PWY, ETT, CT, SMR 74.68
LR + BS SMR, YOS, AGE, PWY, SEX, HPT, INA, CT, MPS, ANG 74.68
DT + SFFS ANG, INA, CTT, ETT 78.63
DT + FS ANG, INA,CT, ETT, DAB, SEX 77.84
SVM + FS ANG, INA, CT, SEX, ETT, PWY, AGE, MPS, CHL,YOS 78.16
SVM + BS YOS, AGE, PWY, SEX, HPT, CHL, INA, CT, MPS, ANG 78.32
Page 15 of 21Farooq and Hussain  Complex Adapt Syst Model  (2016) 4:12 
model, we first determined the optimal number of variables, after applying k-fold cross-
validation strategy, followed by development of prognostic model keeping in view clini-
cal requirements of RACPC. The developed model calculates probability of cardiac chest 
pain. Two additional cardiac chest pain prognostic models have also been developed as 
per the clinical needs of Raigmore hospital’s RACPC. In the second cardiac chest pain 
prognostic model, it was suggested to include additional two clinical variables, “Initial 
Fig. 5 Cardiac chest pain prognostic model’s front end
Fig. 6 Output example of the cardiac chest pain prognostic model
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assessment” and “Angio result”. LR classifier is used in the development of these expert 
driven prognostic models shown in Fig. 7.
Figure 8 shows the third cardiac chest pain prognostic model which is developed to 
calculate cardiac chest pain risk score using minimal set of variables. This cardiac chest 
pain prognostic model provides a cost effective cardiac chest pain risk assessment mech-
anism by using patient demographics and minimal lab test results, thereby reducing cost 
and dependency on CT scan and initial assessment procedures.
Fig. 7 Output example of the Cardiac Chest Pain Prognostic Model
Fig. 8 Output example of the cardiac chest pain prognostic model
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Validation of the machine learning driven system (MLDPS) and ontology driven clinical risk 
assessment and recommendation system (ODCRARS)
Clinical validation of the MLDPS involved testing of the web based prognostic models 
for cardiac chest pain, heart disease and breast cancer. Breast cancer prognostic models 
are not part of the ODCRARS and validation of these clinical models was carried out by 
an oncologist from the Beatson cancer centre in Glasgow. The cardiac chest pain and 
heart disease prognostic models were validated by a consultant cardiologist and a gen-
eral medical practitioner from UK.
The machine learning driven cardiac chest pain prognostic model was developed 
under the supervision of a consultant cardiologist from Raigmore Hospital. This clinical 
model is developed using clinical features extracted in the RACPC clinical case study. 
The model was tested using clinical use cases for non-cardiac and known cardiac chest 
pain patients for clinical validation and sanity checking purposes.
The patient data was generated using the ODCRARS’s web front end. Patient demo-
graphics and past medical history were collated during patient’s review of the system 
which has been conducted using the patient’s interface. The patient data required for 
the cardiac chest pain risk score calculation was populated through the ODCRARS. As 
it can be seen in Fig. 9, system calculates cardiac risk scores for the selected patient for 
various cardiovascular diseases. The outcome risk scores over 4 and 10 year period, cal-
culated using Framingham Heart Study (FHS) are provided in the doctor’s module.
The ODCRARS provides dedicated graphical user interface for the clinicians and 
patients to record their interactions with the system. Cardiologist using the doctor’s inter-
face reviews patient data which was provided during the patient interview, conducted 
through an ontology driven intelligent context-aware information collection component. 
After reviewing patient’s summary data, the clinician carries out clinical risk assessment 
by clicking on the “Risk assessment” button. System brings up information on the front 
end as shown in Fig. 10, which shows details of cardiovascular risk assessment carried out 
Fig. 9 Clinical use case for the validation of ontology driven clinical risk assessment and recommendation 
system
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through ODCRARS. System provides details of cardiac risk scores for CHD, MI, CHD 
Death and Stroke conditions as shown in Fig. 11. It also brings up patient demograph-
ics information as shown in the Fig. 9, this information was provided during the patient 
registration procedure. The cardiologist also carries out cardiac chest pain risk assess-
ment by clicking on the “Calculate score” button. The machine learning driven cardiac 
chest pain prognostic model calculates the cardiac chest pain risk score which is shown 
in Fig.  10. The ODCRARS provides a complete cardiac risk assessment profile for the 
patient selected by the clinician. In the “Risk assessment” module, cardiologist launches 
the machine learning driven heart disease prognostic model by clicking on the “heart dis-
ease prognostic model” link to verify information populated on the screen. Clinician then 
clicks on the “Calculate button to generate the heart disease risk score as shown in Fig. 12.
Clinical validation of the machine learning driven cardiac chest pain and heart disease 
prognostic models was carried out in a limited case study by a general medical practi-
tioner from Edinburgh, Scotland. The focus of this clinical case study was to detect high-
risk patients with ischaemic heart disease by carrying out cardiac risk assessment of 
patients using the machine learning driven prognostic models incorporated in the ‘Risk 
assessment module of the ODCRARS. Clinical trials were conducted using the in-house 
patient data to assess clinical prototypes suitability for general medical practitioners.
The ODCRARS, especially machine learning driven cardiac chest pain and heart dis-
ease prognostic models were presented at various e-health workshops and symposiums. 
The look and feel of these clinical prototypes was refined to incorporate users’ feedback, 
and adherence to usability guidelines for web browsers and mobile phone users. Also, 
clinical prototypes were demonstrated in an invited speaker talk at the Beth Israel Dea-
coness Medical Centre of Harvard Medical School.
Fig. 10 Clinical use case for the validation of ontology driven clinical risk assessment and recommendation 
system
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Conclusions
We have demonstrated the design, development and validation of the machine learning 
driven prognostic system (MLDPS). It has been brought to light as a result of this clinical 
case study that we do not need all of the expensive lab tests to figure out if patient is pre-
senting cardiac chest pain related symptoms. The Initial Assessment, CT and ET lab test 
results could provide the much needed clinical decision support to clinicians to reach 
patient diagnosis. We demonstrated a novel Machine Learning driven Prognostic system 
which was developed to help clinicians automatically distinguish cardiac chest patients 
from others with non-cardiac chest pain.
We have demonstrated clinical effectiveness of our proposed clinical decision sup-
port framework through clinical case studies in the cardiovascular domain. The pro-
posed ontology and machine learning driven hybrid clinical decision support framework 
exploits functionality provided by each of its key components. Moreover, it brings/inte-
grate them together in an intelligent manner to deliver a cost effective, holistic and effi-
cient cardiovascular clinical risk assessment mechanism. The proposed clinical decision 
Fig. 11 Clinical validation of the ontology driven clinical risk assessment and recommendation system 
(ODCRARS)
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support framework could also be utilised in the clinical risk assessment of other chronic 
illnesses. We have also explained the functionality of a comparative machine learning 
and feature selection techniques, used in the development of the prognostic system. The 
MLDPS is validated by clinical domain experts in the RACPC, heart disease and breast 
cancer domains.
Our proposed MLDPS provides prognostic models for the RACPC clinicians to distin-
guish cardiac chest pain patients from those with non-cardiac symptoms. Our proposed 
clinical decision support framework provides a foundation for future clinical decision 
support systems to follow a multi-layered clinical decision support framework approach 
by learning from evidence-based/data driven legacy clinical data. Learning from legacy 
clinical data activity, provides an opportunity to reverse engineer existing clinical work-
flows, in order to remove redundant clinical pathways thereby providing clinicians rec-
ommendations/suggestions to refine clinical workflows.
The proposed clinical decision support framework utilises clinical expert’s knowledge, 
which is encoded in the form of clinical rules for clinical recommendation purposes. 
Also, it makes use of clinical rules (encoded in the form of look-up tables, statistical 
equations) provided in the Framingham Heart Study (FHS) for the cardiac risk score cal-
culation for various cardiovascular diseases.
Fig. 12 Cardiac chest pain risk score calculation as part of the integrated ODCRARS
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